Variable | Â | Training cohort | Â | Testing cohort | Â | ||
---|---|---|---|---|---|---|---|
 | Label = 0 | Label = 1 | P value | Label = 0 | Label = 1 | P value | |
 | N = 153 | N = 53 |  | N = 65 | N = 23 |  | |
Age, years | Â | 45.00 [34.00, 51.00] | 48.00 [35.00, 52.00] | 0.412 | 43.00 [37.00, 50.00] | 45.00 [39.00, 52.50] | 0.283 |
Height | Â | 1.65 [1.60, 1.70] | 1.65 [1.60, 1.70] | 0.674 | 1.65 [1.60, 1.70] | 1.62 [1.54, 1.65] | 0.023 |
Weight, kg | Â | 60.00 [53.00, 66.50] | 59.00 [52.50, 65.00] | 0.523 | 65.00 [57.00, 69.00] | 54.00 [49.25, 61.75] | 0.006 |
BMI | Â | 22.46 [20.08, 24.22] | 21.97 [19.33, 24.22] | 0.329 | 23.44 [20.90, 25.39] | 21.09 [19.83, 23.66] | 0.052 |
Follow-up Time, month |  | 49.00 [37.00, 59.00] | 20.00 [11.00, 33.00] | < 0.001 | 46.00 [37.00, 58.00] | 19.00 [13.00, 24.50] | < 0.001 |
Sex (%) | Female | 44 (28.8) | 11 (20.8) | 0.256 | 20 (30.8) | 6 (26.1) | 0.672 |
 | Male | 109 (71.2) | 42 (79.2) |  | 45 (69.2) | 17 (73.9) |  |
Family (%) | No | 123 (80.4) | 44 (83.0) | 0.674 | 52 (80.0) | 16 (69.6) | 0.305 |
 | Yes | 30 (19.6) | 9 (17.0) |  | 13 (20.0) | 7 (30.4) |  |
Smoke (%) | No | 90 (58.8) | 32 (60.4) | 0.843 | 40 (61.5) | 11 (47.8) | 0.252 |
 | Yes | 63 (41.2) | 21 (39.6) |  | 25 (38.5) | 12 (52.2) |  |
EBV-DNA (%) | 0 | 88 (57.5) | 26 (49.1) | 0.286 | 33 (50.8) | 11 (47.8) | 0.808 |
 | 1 | 65 (42.5) | 27 (50.9) |  | 32 (49.2) | 12 (52.2) |  |
T stage (%) | T1 | 8 (5.2) | 3 (5.7) | 0.355 | 1 (1.5) | 0 (0.0) | 0.473 |
 | T2 | 38 (24.8) | 8 (15.1) |  | 18 (27.7) | 5 (21.7) |  |
 | T3 | 40 (26.1) | 12 (22.6) |  | 22 (33.8) | 5 (21.7) |  |
 | T4 | 67 (43.8) | 30 (56.6) |  | 24 (36.9) | 13 (56.5) |  |
N stage (%) | N0 | 3 (2.0) | 0 (0.0) | 0.363 | 1 (1.5) | 0 (0.0) | 0.307 |
 | N1 | 36 (23.5) | 18 (34.0) |  | 14 (21.5) | 7 (30.4) |  |
 | N2 | 67 (43.8) | 23 (43.4) |  | 23 (35.4) | 11 (47.8) |  |
 | N3 | 47 (30.7) | 12 (22.6) |  | 27 (41.5) | 5 (21.7) |  |
Overall stage (%) | 3 | 51 (33.3) | 16 (30.2) | 0.674 | 21 (32.3) | 6 (26.1) | 0.578 |
 | 4 | 102 (66.7) | 37 (69.8) |  | 44 (67.7) | 17 (73.9) |  |
WHO Grade (%) | I | 2 (1.4) | 1 (1.9) | 0.422 | 2 (3.0) | 0 (0.0) | 0.558 |
 | II | 19 (12.4) | 10 (18.9) |  | 6 (9.2) | 0 (0.0) |  |
 | III | 132 (86.3) | 42 (79.2) |  | 57 (87.7) | 23 (100.0) |  |
WBC | Â | 7.22 [6.21, 8.76] | 6.88 [5.53, 7.99] | 0.079 | 7.17 [6.21, 8.49] | 6.91 [5.70, 8.18] | 0.35 |
Hb | Â | 137.00 [126.00, 150.00] | 138.00 [125.00, 148.00] | 0.646 | 140.00 [129.00, 149.00] | 132.00 [119.50, 143.00] | 0.072 |
PLT | Â | 272.00 [242.00, 332.00] | 289.00 [231.00, 337.00] | 0.934 | 286.00 [234.00, 335.00] | 296.00 [238.00, 325.00] | 0.966 |
NEUT | Â | 4.51 [3.55, 5.70] | 4.39 [3.53, 5.70] | 0.621 | 4.45 [3.60, 5.55] | 3.91 [3.20, 4.94] | 0.086 |
LYMP | Â | 1.87 [1.62, 2.24] | 1.76 [1.42, 2.10] | 0.076 | 1.88 [1.53, 2.32] | 2.00 [1.63, 2.53] | 0.403 |
ALB |  | 0.06 (1.16) | −0.10 (0.90) | 0.377 | −0.11 [−0.48, 0.43] | −0.18 [−0.46, 0.29] | 0.966 |